Bring your co-founder, partner, or colleague and get 50% off a second TechCrunch Disrupt 2026 pass

TechCrunch is offering a buy-one-get-one 50%-off promotion for Disrupt 2026 tickets until the conference opens on October 13 at 8 a.m. PT, with savings of up to $450 depending on pass type. The October 13-15 San Francisco event expects 10,000+ founders, investors and technology leaders, 300+ startups, and 200+ sessions focused on areas including AI, fintech and technology infrastructure. The announcement is a promotional event update with no material public-market implications.

Analysis

This is promotional activity with no discernible read-through to EXPO (Exponent) or public technology valuations. The ticker association appears spurious: Exponent’s revenue is driven by engineering/scientific consulting utilization, billing rates, and litigation-related demand—not startup-conference attendance or venture networking activity. No position should be altered on this item.

At most, the aggressive late-cycle ticket discount is a weak, non-investable indicator that event organizers are optimizing attendance and sponsorship yield rather than signaling an improvement in private-market fundraising. A broader pattern of discounts across major startup events, coupled with falling sponsor commitments or weaker exhibitor counts, could eventually corroborate a softer early-stage funding environment; that would matter more for fee-related earnings at listed alternative managers such as BX, KKR, APO and ARES than for EXPO.

The relevant 1-3 month catalyst for private-market proxies remains fundraising, realizations, and deployment data—not conference traffic. Over 6-18 months, a genuine reopening of venture liquidity would benefit GP-management fees and performance-fee optionality, but one organizer’s pricing tactic offers no basis to underwrite that outcome. Falsify the "no signal" view only if independently reported attendance, sponsor demand, and disclosed deal activity show a material, broad-based acceleration versus prior events.

Key Decisions for Investors

• Take no action in EXPO; exclude this article from the investment evidence set because the named ticker has no economic linkage to the event.
• Maintain any private-markets exposure based on reported fundraising and realization trends. Use BX, KKR, APO and ARES quarterly fee-related earnings guidance and fundraising disclosures as the actionable checkpoints over the next 1-3 months.
• Create a watch alert—not a trade—for corroborating evidence of venture-market improvement: sustained IPO issuance, rising late-stage funding volumes, and improving GP fundraising. Only then evaluate a long alternative-asset-manager basket versus the S&P 500 Financials sector.